Medical Directors

  • Karl Wasserman, M.D., Ph.D. & James Hansen, M.D. JoeProfessor of Medicine, Department of Medicine
    Division of Respiratory and Critical Care
    Harbor – UCLA Medical Center, Research and Education Institute
    Torrance, California

    Drs. Wasserman and Hansen have devoted their professional careers to the development of Cardiopulmonary Exercise Testing as it is today. Together they have written and given hundreds of articles and lectures on the subject. Both are on faculty at Harbor–UCLA Medical Center, Research and Education Institute (REI). REI is currently ranked in the top 5% among all institutes in the United States in terms of NIH funding. Drs. Wasserman and Hansen are responsible for establishing the criteria for and approving which exercise labs might participate in any FDA studies as quality control benefactors.

  • William E. Boden, M.D., F.A.C.C. KarlProfessor of Medicine and Preventive Medicine
    State University of New York at Buffalo Schools of Medicine and Public Health
    Director of Cardiovascular Services
    Kaleida Health System in Western New York
    Chief of Cardiology at Buffalo General and Millard Fillmore Hospitals - Buffalo, New York

    Dr. Boden’s principal research interests include studies in post-myocardial infarction secondary prevention, acute coronary syndromes and unstable angina, congestive heart failure, dyslipidemia in post-myocardial infarction (MI), and coronary artery disease (CAD). He has worked extensively in the clinical trials arena of non-Q-wave MI and in assessing the role of calcium antagonists in patients with ischemic heart disease, notably in non-Q-wave MI secondary prevention. Dr. Boden has been involved in clinical research investigator activities as the project director, study chairman and co-chairman for multicenter clinical trials, and served as a principal investigator, steering committee member, and consultant for numerous clinical research grant activities funded by the Department of Veterans Affairs, the NIH, and industry. He was the study chairman and study co-chairman for the VANQWISH and INTERCEPT trials, respectively. Currently he is the study co-chairman and lead investigator in the COURAGE trial (the largest randomized trial comparison of percutaneous coronary intervention [PCI] versus optimal medical therapy in stable CAD patients), and is the study co-chairman of the NIH-funded AIM-HIGH trial evaluating the long-term role of combination dyslipidemic therapy (niacin and statin vs statin) in CAD patients with low HDL-cholesterol. Since 1979, Dr. Boden has held university appointments at Brown University, Wayne State University, Tufts New England Medical Center, Boston University, the University of Connecticut, and currently at the State University of New York in Buffalo. Dr. Boden has lectured widely and written over 350 peer-reviewed publications, original articles, books, chapters, and abstracts. He has been selected as one of the Best Doctors in America continuously since 2003. He is a member of several professional Cardiology organizations and editorial boards of American Journal of Cardiology, Journal of the American College of Cardiology, Clinical Cardiology, Cardiovascular Reviews and Reports, American Journal of Geriatric Cardiology and Heart Disease: A Journal of Cardiovascular Medicine. Dr. Boden also serves as an editorial reviewer for New England Journal of Medicine, Annals of Internal Medicine, Circulation, Journal of the American Medical Association, Archives of Internal Medicine, American Heart Journal, Chest, American Journal of Electrocardiology, and Journal of Critical Illness.

  • Romualdo Belardinelli, MD, FESC JoeLancisi Heart Institute
    Ancona, Italy

    Professor Belardinelli has been invited as a speaker in many important national and international meetings and congresses (Congresso Italiano di Cardiologica ANMCO, 1998-2005, European Society of Cardiology, 1997-2002,2003,2004,2005, International Society for Heart Research (ISHR), 2001, American Heart Association, 2001 and 2002; British Cardiac Society, 2003, Heart Failure ESC, 2003, Chinese Congress of Cardiology, 2002 and Japanese Congress of Cardiology, 2004 among others). He is the author of more than 100 papers published in leading journals in Cardiology and Physiology (European Heart Journal, Circulation, JACC, NEJM, European Journal of Applied Physiology, Medicine Science and Sports Exercise among others). He is the author of two books in Cardiology and has written chapters for many others.

  • Jonathan Myers, Ph.D., F.A.C.S.M., F.A.A.C.V.P.R. JoeHealth Research Scientist
    VA Palo Alto Health Care System
    Clinical Associate Professor, Stanford University

    Dr Myers is currently a Health Research Scientist at the Palo Alto Veterans Affairs Health Care System, where he directs the Exercise Research Laboratory, and where he has worked since 1992. He is a Clinical Professor of Medicine at Stanford University, and a consultant to the Stanford Sports Medicine Program. He is a Research Career Scientist Award recipient through the Veterans Affairs Rehabilitation Research and Development (VA RR&D) Program. His 25-year body of research has focused on clinical applications of exercise testing and training in patients with chronic heart failure, physical activity and cardiovascular health, and the epidemiology of exercise test responses and physical activity patterns. He presently is principal investigator on projects funded by the National Institutes of Health and the VA RR&D. He earned his bachelors degree from the University of California, Santa Barbara in 1978, his masters degree from San Diego State University in 1982, and his doctorate from the University of Southern California in 1991. He is a former board member of the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), and a current member of numerous committees and writing groups related to exercise testing and rehabilitation, including the AACVPR, American Heart Association (AHA), American College of Sports Medicine (ACSM), American Thoracic Society, and the European Association for Cardiovascular Prevention and Rehabilitation. He was the 1997 recipient of the Michael L. Pollock Established Investigator Award through the AACVPR, and is a fellow of the AACVPR, ACSM, American College of Cardiology (ACC), and the AHA.